Evidence map›Paper›PMID 11071676›Full record

ReviewThe New England journal of medicine2000

Graves' disease.

A P Weetman

Abstract readReview
PubMed Publisher
In one paragraph

Review in The New England journal of medicine, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 266 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
266citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

266 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Rituximab for thyroid-associated ophthalmopathy.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Tocilizumab for thyroid eye disease.The Cochrane database of systematic reviews · 2018
    Pooled it
  6. Association of polymorphisms of rs179247 and rs12101255 in thyroid stimulating hormone receptor intron 1 with an increased risk of Graves' disease: A meta-analysis.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2016
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. The abnormal thyroxine signals triggers podocyte apoptosis in DN mice.In vitro cellular & developmental biology. Animal · 2026
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

206 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

A P WeetmanUniversity of Sheffield Division of Clinical Sciences, Northern General Hospital, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graves DiseaseAntibodiesAntithyroid AgentsCausalityDiagnosis, DifferentialFemaleHumansHyperthyroidismIodine RadioisotopesPregnancyPregnancy ComplicationsReceptors, ThyrotropinRemission InductionThyroidectomyAntibodiesAntithyroid AgentsIodine RadioisotopesReceptors, Thyrotropin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.